Results 111 to 120 of about 114,000 (325)
A rare case presentation of acute myo-pericarditis in a patient with lupus flare [PDF]
, 2021 Luis Caraballo
openalex +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Electrophysiological Mechanisms of Atrial Flutter [PDF]
, 2006 Atrial flutter (AFL) is a common arrhythmia in clinical practice. Several experimental models such as tricuspid regurgitation model, tricuspid ring model, sterile pericarditis model and atrial crush injury model have provided important information about
Chen, Shin-Ann, Tai, Ching- Tai
core +2 more sources
A case of corticosteroid-dependent recurrent pericarditis with different response to two IL-1 blocking agents [PDF]
, 2015 Background: Recurrent pericarditis (RP) represents the most troublesome presentation of pericarditis and has a controversial pathogenesis that crosses infectious, auto-immune and auto-inflammatory pathways.
A von Scheven-Gête +6 more
core +2 more sources
Expanding the Patient Pool for Rilonacept
JACC: Case ReportsRecurrent pericarditis complicates 15%-30% of acute pericarditis cases despite initial anti-inflammatory treatment. The RHAPSODY trial (Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis) showed ...
Emma St. John, MD +9 more
doaj +1 more source
Tumor Lysis Syndrome Rare Presentation As Uremic Pericarditis: A Case Report [PDF]
, 2023 Fábio Caleça Emídio +3 more
openalex +1 more source
Circulation Journal, 2008 Constrictive pericarditis (CP) is characterized by scarring and loss of elasticity of the pericardium, resulting in external impedance of cardiac filling. In the developed world, CP is most frequently encountered as a consequence of previous cardiac surgery, thoracic irradiation, viral or idiopathic causes.
Partho P, Sengupta +2 more
openaire +3 more sources
Association between CMR‐derived hepatic T1‐time, tricuspid regurgitation and survival
European Journal of Clinical Investigation, EarlyView.We investigated the association between tricuspid regurgitation (TR) severity and hepatic T1‐time in 1029 patients undergoing cardiac MRI and echocardiography. Hepatic T1‐time increased progressively with TR severity and remained independently associated after adjusting for NT‐proBNP and right ventricular function. Both TR and hepatic T1‐time predicted
Katharina Mascherbauer +19 more
wiley +1 more source
PERICARDITIS CONSTRICTIVA EN UNA MUJER DE 36 AÑOS / Constrictive Pericarditis in a 36 year-old woman [PDF]
, 2012 ResumenPaciente femenina, de 36 años de edad, con antecedentes de dos gestaciones, dos partos y ningún aborto, que en el año 2003 tras su segundo parto, distócico por cesárea, desarrolla una pericarditis de causa no precisada que produjo un derrame ...
Guillermo R. Quintana Cañizárez +2 more
core
Diagnosis and Management of Tuberculous Pericarditis: What Is New?
Current Cardiology Reports, 2020 Purpose of Review This review provides an update on the immunopathogenesis of tuberculous pericarditis (TBP), investigations to confirm tuberculous etiology, the limitations of anti-tuberculous therapy (ATT), and recent efficacy trials. Recent Findings A
G. Isiguzo +3 more
semanticscholar +1 more source